Search results for: “keytruda”
-
Blog
Henrik Vad Madsen’s Immunotherapy Story
Melanoma | Diagnosed 2003 My approach was to say: I have cancer, but I want to have a… -
Blog
Pembrolizumab Approved for Children and Adults with Hard-to-Treat Hodgkin Lymphoma
Pembrolizumab is second anti-PD-1 drug approved for adults with cHL, first for any childhood cancer
-
Blog
T.J. Sharpe’s Immunotherapy Story
Melanoma | Diagnosed 2012 When I was in the hospital, I made a vow that when I was… -
Blog
Immunotherapy Shows Promise Against Previously Untreatable Stomach Cancer
Nivolumab improves survival in patients with advanced stomach cancer.
-
Blog
2016: The Year of Cancer Immunotherapy
New immunotherapy approvals, “Advance of the Year” recognition, and the partnerships of the future.
-
Blog
CNN Highlights Cancer Immunotherapy Advances, CRI’s Pioneering Role
First-line lung cancer immunotherapy approval results from century-long effort to harness the immune system to fight cancer.
-
Blog
Checkpoint Inhibitors Benefit Lung Cancer Patients in Clinical Trials
Patients with metastatic non-small cell lung cancer could soon have a new first-line immunotherapy treatment option.
-
Blog
CICON16: Beyond PD-1 and CTLA-4: The New Checkpoints
The latest advances in using new checkpoint drugs to target LAG-3, Nrp1, IL-35R, CD36, and mitochondrial metabolism.
-
Media Room Article
Cancer Research Institute to Honor Three Scientists for Outstanding Contributions to Cancer Immunotherapy Research
CRI will bestow its highest honors on three scientists who have made seminal contributions to the fields…